Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy.

Authors

null

Masatoshi Kudo

Kindai University Faculty of Medicine, Osaka, Japan

Masatoshi Kudo , Baek-Yeol Ryoo , Ho Yeong Lim , Do Young Kim , Takuji Okusaka , Masafumi Ikeda , Hisashi Hidaka , Jong-Eun Yeon , Eishiro Mizukoshi , Manabu Morimoto , Myung Ah Lee , Kohichiroh Yasui , Yasunori Kawaguchi , Jeong Heo , Sojiro Morita , Tae-You Kim , Junji Furuse , Kazuhiro Katayama , Takeshi Aramaki , Won-Young Tak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Prevention, Diagnosis, and Screening

Clinical Trial Registration Number

NCT02400788

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 252)

DOI

10.1200/JCO.2017.35.4_suppl.252

Abstract #

252

Poster Bd #

B8

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting

Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.

Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.

First Author: Lynn G. Feun

Poster

2018 Gastrointestinal Cancers Symposium

Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.

Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.

First Author: Sunyoung S. Lee

First Author: Mingyue Cai